Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUM001 (Maralixibat) + UDCA in Primary Biliary Cholangitis
NCT01904058Phase 2Completed
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Aug 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of maralixibat in primary biliary cholangitis (PBC), sponsored by Mirum Pharmaceuticals, Inc.. Started Aug 2013; status: completed.
02
Drugs
maralixibat
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT01904058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01904058.